These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20878131)
21. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation. Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648 [TBL] [Abstract][Full Text] [Related]
22. Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line. Vangipuram SD; Buck SA; Lyman WD Tumour Biol; 2012 Dec; 33(6):2173-83. PubMed ID: 22886526 [TBL] [Abstract][Full Text] [Related]
23. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy. Li J; Chen JN; Zeng TT; He F; Chen SP; Ma S; Bi J; Zhu XF; Guan XY BMC Cancer; 2016 Jan; 16():15. PubMed ID: 26758620 [TBL] [Abstract][Full Text] [Related]
24. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240 [TBL] [Abstract][Full Text] [Related]
25. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Guo R; Wu Q; Liu F; Wang Y Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969 [TBL] [Abstract][Full Text] [Related]
26. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Rappa G; Fodstad O; Lorico A Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032 [TBL] [Abstract][Full Text] [Related]
27. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis. Huang X; Sheng Y; Guan M Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578 [TBL] [Abstract][Full Text] [Related]
28. Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma. Cournoyer S; Nyalendo C; Addioui A; Belounis A; Beaunoyer M; Aumont A; Teira P; Duval M; Fernandes K; Fetni R; Haddad E; Sartelet H Genes Chromosomes Cancer; 2012 Aug; 51(8):792-804. PubMed ID: 22514116 [TBL] [Abstract][Full Text] [Related]
29. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells. Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669 [TBL] [Abstract][Full Text] [Related]
30. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
31. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
32. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624 [TBL] [Abstract][Full Text] [Related]
33. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells. Wei X; He J; Wang J; Yang X; Ma B Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615 [TBL] [Abstract][Full Text] [Related]
34. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
35. XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1. Tian X; Hou W; Bai S; Fan J; Tong H; Xu H Int J Oncol; 2014 Jul; 45(1):121-8. PubMed ID: 24789807 [TBL] [Abstract][Full Text] [Related]
36. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells. Liu YM; Li XF; Liu H; Wu XL Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320 [TBL] [Abstract][Full Text] [Related]
37. Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. Mahller YY; Williams JP; Baird WH; Mitton B; Grossheim J; Saeki Y; Cancelas JA; Ratner N; Cripe TP PLoS One; 2009; 4(1):e4235. PubMed ID: 19156211 [TBL] [Abstract][Full Text] [Related]
38. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells. Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126 [TBL] [Abstract][Full Text] [Related]
39. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related]
40. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Lai CY; Schwartz BE; Hsu MY Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]